Scleroderma Foundation
- Research works
- 109 ▲ 18% vs 2013–17
- Citations
- 2.8k 25.9 per fractional work
- Top-10% rate
- 32.4% record average 16.5%
- Open access
- 64% world 28%
Not ranked overall: Scleroderma Foundation is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
What does Scleroderma Foundation specialise in?
Where its research is concentrated relative to its size: Medicine takes 4.4× the share of its output that it takes of world research.
- MedicineField · 22.6 works4.4×
- Health SciencesDomain · 23.3 works3.8×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.4×. Every wedge is a field page.
- Medicine 4.4×
- Immunology and Microbiology 2.9×
- Biochemistry, Genetics and Molecular Biology 1.2×
- Health Professions 0.9×
- Neuroscience 0.5×
- Psychology 0.3×
- Business, Management and Accounting 0.2×
- Social Sciences 0.1×
- Engineering 0.1×
- Agricultural and Biological Sciences 0.0×
- Economics, Econometrics and Finance 0.0×
- Computer Science 0.0×
- Environmental Science 0.0×
Which keywords describe research at Scleroderma Foundation?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Autoantibodies, Fibrosis, Treatment, Endothelial Dysfunction, TGF-ß Signaling, Immunosuppressive Therapy, Pulmonary Involvement and Systemic Sclerosis.
- Neuromyelitis Optica
- Epidemiology
- Myofibroblast
- Idiopathic Pulmonary Fibrosis
- TGF-ß
- Systemic Sclerosis
- Immunosuppressive Therapy
- Endothelial Dysfunction
- Fibrosis
- Autoantibodies
- Treatment
- TGF-ß Signaling
- Pulmonary Involvement
- Interstitial Lung Disease
- Dermatomyositis
- Inflammatory Myopathies
- Diagnostic Criteria
- Multiple Sclerosis
- Inflammation
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 19 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 19 words, with their numbers
- Autoantibodies12▲ 187×6 topics
- Fibrosis11▲ 228×4 topics
- Treatment11▲ 34×7 topics
- Endothelial Dysfunction9▲ 147×2 topics
- TGF-ß Signaling9▲ 518×2 topics
- Immunosuppressive Therapy9▲ 176×3 topics
- Pulmonary Involvement9▲ 889×1 topic
- Systemic Sclerosis9▲ 889×1 topic
- Interstitial Lung Disease5▲ 271×2 topics
- TGF-ß2▲ 58×2 topics
- Dermatomyositis2▲ 495×1 topic
- Idiopathic Pulmonary Fibrosis2▲ 188×1 topic
- Inflammatory Myopathies2▲ 495×1 topic
- Myofibroblast2▲ 188×1 topic
- Diagnostic Criteria2▲ 26×3 topics
- Epidemiology2▲ 1.41×11 topics
- Multiple Sclerosis2▲ 148×1 topic
- Neuromyelitis Optica2▲ 148×1 topic
- Inflammation1▲ 1.83×8 topics
Which research topics does Scleroderma Foundation publish most on?
By volume in 2022–2025: Systemic Sclerosis and Related Diseases, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Inflammatory Myopathies and Dermatomyositis and Multiple Sclerosis Research Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 9 works
- 2 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 2 works
- 3 Inflammatory Myopathies and Dermatomyositis Epidemiology 2 works
- 4 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 2 works
- 5 Dermatologic Treatments and Research Dermatology 1 works
- 6 Respiratory Support and Mechanisms Pulmonary and Respiratory Medicine 0 works
- 7 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 0 works
- 8 Skin Diseases and Diabetes Dermatology 0 works
- 9 Diagnosis and Treatment of Venous Diseases Surgery 0 works
- 10 Rheumatoid Arthritis Research and Therapies Rheumatology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Scleroderma Foundation's research output changed?
Output in 2018–2022 was 18% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Danvers
- Cell Signaling Technology (United States)
- North Shore Community College
- Hamilton Thorne (United States)
- Abiomed (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.